HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects.

Abstract
We evaluated the effects of NT-702 (parogrelil hydrochloride, NM-702, 4-bromo-6-[3-(4-chlorophenyl) propoxy]-5-[(pyridine-3-ylmethyl) amino] pyridazin-3(2H)-one hydrochloride), a selective phosphodiesterase 3 inhibitor, on the asthmatic response in guinea pigs. NT-702 at a concentration of 1 x 10(-7)M elevated the cyclic adenosine monophosphate content in prostaglandin E(2)-treated guinea pig tracheal smooth muscle cells. Leukotriene (LT) D(4)- and histamine-induced contraction of isolated guinea pig tracheal strips was inhibited by NT-702, with EC(50) values of 3.2 x 10(-7) and 2.5 x 10(-7)M, respectively. In an in vivo study, NT-702 suppressed LTD(4)-induced bronchoconstriction and the ovalbumin-induced immediate asthmatic response in guinea pigs through its bronchodilating effect. Furthermore, NT-702 also suppressed the ovalbumin-induced late asthmatic response, airway hyperresponsiveness, and the accumulation of inflammatory cells in the bronchoalveolar lavage fluid. These results suggest that NT-702 has an anti-inflammatory effect as well as a bronchodilating effect and might be useful as a novel potent therapeutic agent for the treatment of bronchial asthma, a new type of agent with both a bronchodilating and an anti-inflammatory effect.
AuthorsMiyuki Hori, Takehisa Iwama, Yumiko Asakura, Masafumi Kawanishi, Junji Kamon, Akihiko Hoshino, Shuya Takahashi, Kenzo Takahashi, Shiro Nakaike, Nobutomo Tsuruzoe
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 618 Issue 1-3 Pg. 63-9 (Sep 15 2009) ISSN: 1879-0712 [Electronic] Netherlands
PMID19616537 (Publication Type: Journal Article)
Chemical References
  • 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2H)-pyridazinone hydrochloride
  • Anti-Inflammatory Agents
  • Antigens
  • Bronchodilator Agents
  • Enzyme Inhibitors
  • Phosphodiesterase 3 Inhibitors
  • Pyridazines
  • Leukotriene D4
  • Histamine
  • Cyclic AMP
  • Dinoprostone
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Antigens (immunology)
  • Asthma (drug therapy, metabolism, pathology, physiopathology)
  • Bronchoconstriction (drug effects, immunology)
  • Bronchodilator Agents (pharmacology, therapeutic use)
  • Cell Movement (drug effects)
  • Cyclic AMP (metabolism)
  • Dinoprostone (pharmacology)
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Guinea Pigs
  • Histamine (pharmacology)
  • In Vitro Techniques
  • Leukotriene D4 (pharmacology)
  • Lung (drug effects, pathology)
  • Male
  • Muscle Contraction (drug effects)
  • Muscle, Smooth (drug effects, physiopathology)
  • Phosphodiesterase 3 Inhibitors
  • Pyridazines (pharmacology, therapeutic use)
  • Trachea (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: